SG Americas Securities
ATOS icon

SG Americas Securities’s Atossa Therapeutics ATOS Stock Holding History

SG Americas Securities’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,483
Closed -$25K – 2933
2025
Q1 		$25K Sell
2,483
-4,441
-64% -$53.9K ﹤0.01% 3356
2024
Q4 		$98K Buy
6,924
+4,134
+148% +$80.7K ﹤0.01% 2750
2024
Q3 		$64K Buy
2,790
+2,003
+255% +$40.4K ﹤0.01% 3190
2024
Q2 		$14K Buy
+787
New +$17.4K ﹤0.01% 2774
2022
Q2 		– Sell
-728
Closed -$14K – 3411
2022
Q1 		$14K Sell
728
-1,690
-70% -$34.3K ﹤0.01% 2895
2021
Q4 		$58K Sell
2,418
-3,059
-56% -$112K ﹤0.01% 3172
2021
Q3 		$268K Buy
+5,477
New +$319K ﹤0.01% 3023

Other funds holding ATOS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SG Americas Securities's ATOS Position: Q2 2025 in Review

SG Americas Securities sold out of Atossa Therapeutics (ATOS) in Q2 2025, closing a stake of 2,483 shares — an estimated $25K sold.

SG Americas Securities first reported a position in ATOS in Q3 2021 and held it in 7 quarters. The position peaked at $268K in Q3 2021. 84 funds tracked by Wall St. Rank hold ATOS as of Q2 2025.

  • SG Americas Securities reported no remaining Atossa Therapeutics position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 2,483 Atossa Therapeutics shares in Q2 2025, an estimated $25K.
  • SG Americas Securities first reported a position in Atossa Therapeutics in Q3 2021 and held it in 7 quarters.
  • SG Americas Securities's Atossa Therapeutics position peaked at $268K in Q3 2021.
  • 84 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.